These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 17099832

  • 1. [Extended metabolic diagnosis of urolithiasis].
    Laube N, Bradenahl J, Thomas E, Meissner A, Müller SC.
    Aktuelle Urol; 2006 Nov; 37(6):436-42; quiz 423-4. PubMed ID: 17099832
    [Abstract] [Full Text] [Related]

  • 2. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
    Laube N, Hergarten S, Hoppe B, Schmidt M, Hesse A.
    J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
    [Abstract] [Full Text] [Related]

  • 3. Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?
    Kavanagh JP, Laube N.
    J Urol; 2006 Feb; 175(2):766-70. PubMed ID: 16407047
    [Abstract] [Full Text] [Related]

  • 4. Bonn Risk Index based micromethod for assessing risk of urinary calcium oxalate stone formation.
    Porowski T, Mrozek P, Sidun J, Zoch-Zwierz W, Konstantynowicz J, Kirejczyk JK, Motkowski R, Laube N.
    J Urol; 2010 Mar; 183(3):1157-62. PubMed ID: 20096860
    [Abstract] [Full Text] [Related]

  • 5. [Monitoring of the treatment of calcium-oxalate stone formers with the Bonn-Risk-Index].
    Laube N, Schmidt M, Hesse A.
    Urologe A; 2003 Feb; 42(2):243-9. PubMed ID: 12607094
    [Abstract] [Full Text] [Related]

  • 6. The alteration of urine composition due to stone material present in the urinary tract.
    Laube N, Pullmann M, Hergarten S, Schmidt M, Hesse A.
    Eur Urol; 2003 Nov; 44(5):595-9. PubMed ID: 14572760
    [Abstract] [Full Text] [Related]

  • 7. [Risk of lithiasis and urolithiasis in children with unspecific inflammatory bowel disease].
    Makosiej R, Czkwianianc E, Niedworok M, Małecka-Panas E.
    Pol Merkur Lekarski; 2007 May; 22(131):410-3. PubMed ID: 17679383
    [Abstract] [Full Text] [Related]

  • 8. The influence of freezer storage of urine samples on the BONN-Risk-Index for calcium oxalate crystallization.
    Laube N, Zimmermann DJ.
    Clin Chem Lab Med; 2004 May; 42(6):665-9. PubMed ID: 15259384
    [Abstract] [Full Text] [Related]

  • 9. Urinary metabolic evaluations in normal and stone forming children.
    DeFoor W, Asplin J, Jackson E, Jackson C, Reddy P, Sheldon C, Erhard M, Minevich E.
    J Urol; 2006 Oct; 176(4 Pt 2):1793-6. PubMed ID: 16945651
    [Abstract] [Full Text] [Related]

  • 10. Can the Bonn Risk Index be replaced by a simple measurement of the urinary concentration of free calcium ions?
    Laube N, Hergarten S.
    J Urol; 2005 Jun; 173(6):2175-7. PubMed ID: 15879882
    [Abstract] [Full Text] [Related]

  • 11. Computation and modeling of the stone-growth related urinary depletion effect using "depletion V1.0".
    Laube N, Pullmann M.
    Eur J Med Res; 2006 Dec 14; 11(12):534-9. PubMed ID: 17182366
    [Abstract] [Full Text] [Related]

  • 12. A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index.
    Porowski T, Zoch-Zwierz W, Konstantynowicz J, Taranta-Janusz K.
    Pediatr Nephrol; 2008 Jul 14; 23(7):1123-8. PubMed ID: 18335253
    [Abstract] [Full Text] [Related]

  • 13. Calcium oxalate stone formation risk - a case of disturbed relative concentrations of urinary components.
    Laube N, Rodgers A, Allie-Hamdulay S, Straub M.
    Clin Chem Lab Med; 2008 Jul 14; 46(8):1134-9. PubMed ID: 18578688
    [Abstract] [Full Text] [Related]

  • 14. [New diagnostic tool for individual monitoring of urolithiasis risk and other metabolic diseases].
    Laube N, Klein F, Bernsmann F, Fisang C.
    Dtsch Med Wochenschr; 2014 Aug 14; 139(34-35):1721-5. PubMed ID: 25116022
    [Abstract] [Full Text] [Related]

  • 15. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.
    Gohel MD, Shum DK, Tam PC.
    Carbohydr Res; 2007 Jan 15; 342(1):79-86. PubMed ID: 17145044
    [Abstract] [Full Text] [Related]

  • 16. Urinary macromolecules and renal tubular cell protection from oxalate injury: comparison of normal subjects and recurrent stone formers.
    Tsujihata M, Tsujikawa K, Tei N, Yoshimura K, Okuyama A.
    Int J Urol; 2006 Mar 15; 13(3):197-201. PubMed ID: 16643608
    [Abstract] [Full Text] [Related]

  • 17. Studies on the role of urinary macromolecules in urolithiasis: review of methodologies and a proposal for a standard reference crystallization system.
    Rodgers AL, Jappie D.
    Scanning Microsc; 1996 Mar 15; 10(2):535-45; discussion 545-6. PubMed ID: 9813630
    [Abstract] [Full Text] [Related]

  • 18. [The phenomenon of the pathological crystallization of stone-forming urinary salts in urolithiasis].
    Shatokhina SN, Shabalin VN.
    Urol Nefrol (Mosk); 1998 Mar 15; (2):16-9. PubMed ID: 9577696
    [Abstract] [Full Text] [Related]

  • 19. Kinetics of calcium oxalate crystal formation in urine.
    Laube N, Klein F, Bernsmann F.
    Urolithiasis; 2017 Apr 15; 45(2):151-157. PubMed ID: 27328814
    [Abstract] [Full Text] [Related]

  • 20. Analytical precision of the Urolizer for the determination of the BONN-Risk-Index (BRI) for calcium oxalate urolithiasis and evaluation of the influence of 24-h urine storage at moderate temperatures on BRI.
    Berg W, Bechler R, Laube N.
    Clin Chem Lab Med; 2009 Apr 15; 47(4):478-82. PubMed ID: 19222375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.